ArticlePharmaceutics2018

DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways.

Zaid H Maayah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.